BRITTON WHALEN: Open Payments
NPI 1437914538 · TULARE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,240 in 153 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $1,136 · 2025 $2,240
Food & beverage: $2,155Education: $85
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 48 | $553 |
| ABBVIE INC. | 20 | $442 |
| Incyte Corporation | 23 | $329 |
| Verrica Pharmaceuticals Inc. | 27 | $310 |
| Janssen Biotech, Inc. | 11 | $198 |
| Organon LLC | 14 | $179 |
| GENZYME CORPORATION | 3 | $68 |
| Galderma Laboratories, L.P. | 1 | $39 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $38 |
| UCB, Inc. | 1 | $35 |
Products named: Zoryve, OPZELURA, YCANTH, SKYRIZI, TREMFYA, RINVOQ, DUPIXENT, VTAMA.
Industry payments across CA — which companies pay providers there.
